Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never been greater. Genomics has the potential to improve the process of vaccine development substantially. Genome sequencing can help to identify genetic patterns related to the virulence of a disease, as well as genetic factors that contribute to immunity or successful vaccine response. All this information could lead to vaccines with better and more specific targets that elicit more successful protective immune responses. Comparing the genome sequences of viruses that cause infection with those that do not may provide additional insights. In turn, genome manipulation can facilitate derivation of attenuated strains or other vehicles for delivery of the desired antigens to stimulate immune response. On the other end of the spectrum, analysis of host diversity can reveal effective immune responses and possibly the genetic basis for inappropriate response. The recent progress in definition of the innate immune system, necessary for acquired response, should facilitate the definition of this host diversity.
Answer:
Telling the adolescent that the prescribed dose of rapid-acting insulin should be administered
Answer:
The best answer to the question: A nurse is monitoring the laboratory values of a client who is receiving heparin. Which of the following values should a nurse report to the provider? would be: D: aPTT of 50 seconds.
Explanation:
Unlike Warfarin and the low-molecular weight heparin, medically speaking, the one diagnostic test that is still being used as a measure of heparin´s therapeutic achievements in a patient with a coagulopathy, is the activated partial thromboplastin time aPTT. Although the measurement in seconds, will depend on the laboratory that is doing the measuring, and despite scientific evidence that points to the fact that aPTT is not the most accurate of laboratory measurements for a patient with heparin, it is still being used today and still is the leading laboratory test for these types of patients.
